

| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $7.9M | +37.5% |
| R&D Expense | $61.5M | -15.8% |
| SG&A Expense | $22.5M | -1.7% |
| Operating Income | -$76.2M | +15.6% |
| Income Tax | $0 | — |
| Net Income | -$69.2M | +21.5% |
| EPS (Basic) | -$1.83 | +22.5% |
| EPS (Diluted) | -$1.83 | +22.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $10.8M | +16.9% |
| Short-term Investments | $91.4M | -42.8% |
| Current Assets | $105.7M | -38.8% |
| Total Assets | $159.8M | -29.9% |
| Current Liabilities | $20.5M | -11.5% |
| Total Liabilities | $47.0M | -16.4% |
| Stockholders' Equity | $112.7M | -34.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$69.5M | +9.1% |
| Capital Expenditures | $206K | -89.5% |
| Investing Cash Flow | $71.0M | +22.8% |
| Financing Cash Flow | $253K | -49.7% |
| Free Cash Flow | -$69.7M | +11.1% |